High comprehensive complication index after minimally invasive esophagectomy associated with poor short-term and long-term outcome: a propensity score matching analysis [0.03%]
高综合并发症指数与微创食管切除术短期和长期结局较差相关：倾向性匹配分析
Xiaoqing Wang,Jingchuan Yu,Shuhan Xie et al.
Xiaoqing Wang et al.
Introduction: The comprehensive complication index (CCI) is a valuable index to comprehensively and systematically evaluate complication severity. This study aimed to evaluate the predictive ability of comprehensive compl...
Differentiation between G3 pancreatic neuroendocrine tumor and pancreatic neuroendocrine carcinoma based on intratumor and peritumor CT value ratio and abnormal vascular network [0.03%]
基于肿瘤内和瘤周CT值比及异常血管网鉴别胰腺三级神经内分泌肿瘤与神经内分泌癌
Chaoyang Zhang,Wei Hao
Chaoyang Zhang
Background: To develop a model based on computed tomography (CT) images to differentiate between grade 3 (G3) pancreatic neuroendocrine tumors (pNETs) and pancreatic neuroendocrine carcinoma (pNECs). ...
Immune-related osteitis mimicking femoral head osteonecrosis during dual checkpoint blockade: a case report [0.03%]
免疫相关性骨炎模拟双检查点抑制过程中的股骨头坏死：病例报告
Enrica Teresa Tanda,Agostina Lagodin D&#x;Amato,Giovanni Rossi et al.
Enrica Teresa Tanda et al.
Immune checkpoint inhibitors (ICIs) have dramatically reshaped the therapeutic landscape of oncology, offering long-term survival benefits across multiple tumor types. However, ICIs are associated with a broad range of immune-related advers...
The prognostic significance of incomplete hematological recovery in pediatric patients with low/intermediate risk AML and negative MRD after induction 1 [0.03%]
诱导缓解第一疗程后分子生物学微小残留灶阴性的中低危儿童急性髓系细胞白血病患者预后的血常规评估指标意义研究
Nessma M Shahin,Mahmoud Hammad,Hanafy Hafez et al.
Nessma M Shahin et al.
Background: Pediatric acute myeloid leukemia (AML) accounts for approximately 25% of childhood hematologic malignancies. Outcomes have markedly improved, especially in low-risk and intermediate-risk patients, with overall...
Case Report: Diagnostic dilemma: a rare case of oesophageal hyaline vascular unicentric Castleman's disease mimicking carcinoma [0.03%]
病例报告：诊断难题：一例罕见的食道透明血管单中心Castleman病误诊为癌症
Qingqing Cai,Leqing Zhu,Quanwei Guo et al.
Qingqing Cai et al.
Castleman's disease (CD) is a rare, benign lymphoproliferative disorder of unknown aetiology. CD occurring in the oesophageal region is exceedingly rare and may be misdiagnosed as oesophageal carcinoma or lymphoma, thus posing challenges fo...
Is radioiodine necessary for patients with low-risk differentiated thyroid cancer after thyroidectomy: a pooled analysis of ESTIMABL2 and IoN trials [0.03%]
分化型甲状腺癌患者术后低危状态是否需要碘131治疗：ESTIMABL2和IoN研究的合并分析
Chuansheng Yang,Deping Luo,Jian Xie et al.
Chuansheng Yang et al.
Background: The clinical utility of postoperative radioiodine therapy in patients with low-risk differentiated thyroid cancer (DTC) remains a subject of ongoing debate. Although radioiodine has been widely employed to red...
Preoperative absolute neutrophil count: a potential indicator for prognosis in carcinoembryonic antigen normal stage I non-small cell lung cancer [0.03%]
癌胚抗原正常的Ⅰ期非小细胞肺癌患者术前绝对中性粒细胞计数可能是预后的潜在指标
Bailin Wang,Long Liu,Meiqi Cui et al.
Bailin Wang et al.
Background: Carcinoembryonic antigen (CEA) is still the most valuable tumor marker in the diagnosis and prognosis of non-small cell lung cancer (NSCLC) patients; however, its application is largely limited by its low sens...
Primary high-grade urothelial carcinoma of the prostate combined with acinar adenocarcinoma: first rare case report and treatment experience summary [0.03%]
原发前列腺高级别尿路上皮癌合并导管腺癌一例并文献复习
Ting Hu,Yisha Liu,Yu Nie et al.
Ting Hu et al.
Introduction: Primary high-grade urothelial carcinoma of the prostate (PHUCP) combined with acinar adenocarcinoma is an extremely rare malignancy, with no previously reported cases worldwide. Primary urothelial carcinoma ...
Advances in glycolysis research in gastric cancer: molecular mechanisms, regulatory networks, and therapeutic potential [0.03%]
胃癌糖酵解研究进展：分子机制、调控网络与治疗潜力
Jungang Dong,Weiyan Li,Liang Ma et al.
Jungang Dong et al.
Glycolysis is a central metabolic pathway in cancer cells, contributing significantly to the initiation, progression, and therapeutic resistance of gastric cancer. Advances in molecular biology and metabolomics have clarified the regulatory...